1. Home
  2. TKNO vs DRDB Comparison

TKNO vs DRDB Comparison

Compare TKNO & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • DRDB
  • Stock Information
  • Founded
  • TKNO 1996
  • DRDB 2024
  • Country
  • TKNO United States
  • DRDB United States
  • Employees
  • TKNO N/A
  • DRDB N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • DRDB
  • Sector
  • TKNO Health Care
  • DRDB
  • Exchange
  • TKNO Nasdaq
  • DRDB Nasdaq
  • Market Cap
  • TKNO 356.4M
  • DRDB 307.3M
  • IPO Year
  • TKNO 2021
  • DRDB 2024
  • Fundamental
  • Price
  • TKNO $5.75
  • DRDB $10.30
  • Analyst Decision
  • TKNO Buy
  • DRDB
  • Analyst Count
  • TKNO 1
  • DRDB 0
  • Target Price
  • TKNO $5.00
  • DRDB N/A
  • AVG Volume (30 Days)
  • TKNO 421.2K
  • DRDB 133.1K
  • Earning Date
  • TKNO 05-08-2025
  • DRDB 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • DRDB N/A
  • EPS Growth
  • TKNO N/A
  • DRDB N/A
  • EPS
  • TKNO N/A
  • DRDB N/A
  • Revenue
  • TKNO $38,250,000.00
  • DRDB N/A
  • Revenue This Year
  • TKNO $8.73
  • DRDB N/A
  • Revenue Next Year
  • TKNO $16.53
  • DRDB N/A
  • P/E Ratio
  • TKNO N/A
  • DRDB $588.97
  • Revenue Growth
  • TKNO 3.79
  • DRDB N/A
  • 52 Week Low
  • TKNO $1.16
  • DRDB $9.87
  • 52 Week High
  • TKNO $10.37
  • DRDB $10.31
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 40.50
  • DRDB N/A
  • Support Level
  • TKNO $5.59
  • DRDB N/A
  • Resistance Level
  • TKNO $6.01
  • DRDB N/A
  • Average True Range (ATR)
  • TKNO 0.37
  • DRDB 0.00
  • MACD
  • TKNO -0.10
  • DRDB 0.00
  • Stochastic Oscillator
  • TKNO 11.39
  • DRDB 0.00

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

Share on Social Networks: